Obstructive Sleep Apnea News and Research

RSS

Obstructive sleep apnea (OSA) is a major heath problem. In the United States, at least 17 million people have moderate to severe OSA, which is characterized by heavy snoring, airway blockage and frequent awakenings during sleep.

Wake-promoting drug improves alertness in early morning shift workers

Many more people work very early morning shifts than overnight ones, and a large proportion struggle with excessive sleepiness from shift work disorder, leading to problems with focus, performance and safety.

29 Jan 2026

Eating melatonin-rich foods is linked to lower obesity and depression rates

This cross-sectional analysis of 8,320 Brazilian adults quantified melatonin intake from habitual diets and examined associations with multiple chronic health outcomes. Higher dietary melatonin intake was inversely associated with obesity and depression in a non-linear pattern, with no significant associations observed for other conditions.

28 Jan 2026

New role for GLP-1 drugs: Improving survival in people with severe psychiatric disorders

This editorial argues that GLP-1 receptor agonists could substantially improve healthspan and reduce premature mortality in people with serious mental illnesses by targeting cardiometabolic risk rather than psychiatric symptoms alone. It highlights emerging evidence, safety considerations, and equity challenges that position GLP-1 RAs as a promising public health strategy for this high-risk population.

25 Jan 2026

Real-time smartphone monitoring improves evaluation of insomnia treatment effectiveness

About one in nine adults suffer from chronic insomnia and its residual effects like drowsiness, cognitive issues, and irritability as well as increased health risks like diabetes and heart risks if left untreated.

8 Jan 2026

Study examines fairness of oxygen desaturation thresholds in sleep apnea diagnosis

Obstructive sleep apnea (OSA) is a common sleep disorder in the U.S. affecting tens of millions, with estimates ranging from 25 to more than 80 million adults.

17 Dec 2025

New evidence supports ablation for high-risk patients with AFib and sleep apnea

Obstructive sleep apnea and atrial fibrillation are two conditions that share a potentially deadly link. Having one increases the odds of developing the other, and together, the breathing difficulties of sleep apnea combined with the irregular heartbeat of atrial fibrillation (AFib) can result in life-threatening cardiovascular risks.

1 Dec 2025

Older women with comorbid insomnia and sleep apnea show worse memory performance

New research among older adults with sleep apnea reveals that verbal memory performance is significantly worse in women - but not in men - who also have insomnia.

1 Dec 2025

Treating sleep apnea can lower Parkinson’s disease risk

Researchers report that obstructive sleep apnea increases the risk of Parkinson’s disease however, this risk can be attenuated by positive airway pressure.

1 Dec 2025

New study links untreated sleep apnea to higher Parkinson’s disease risk

New research reveals that people with untreated obstructive sleep apnea have a higher risk of developing Parkinson's disease. However, they can significantly reduce the risk by improving the quality of their sleep by using continuous positive airway pressure, or CPAP.

24 Nov 2025

Exosomes identified as key mediators in obstructive sleep apnea and its comorbidities

Obstructive sleep apnea (OSA), a global public health issue marked by repeated upper airway collapse during sleep, is tied to diverse diseases-from cardiovascular conditions to cancer.

12 Nov 2025

How gut microbes shape sleep: New review reveals microbiome clues to insomnia and apnea

A new Brain Medicine review maps how gut microbes influence sleep disorders, from insomnia and sleep apnea to circadian disruption, via bile acids, neurotransmitters, and immune pathways. The findings highlight gut-driven targets for improving sleep quality through diet, probiotics, and microbiome modulation.

5 Nov 2025

GLP-1 drugs calm inflammation beyond diabetes and weight loss

This Journal of Clinical Investigation review describes how glucagon-like peptide-1 (GLP-1)–based medicines reduce systemic and tissue inflammation through both weight-dependent and weight-independent mechanisms. It details preclinical and clinical evidence linking GLP-1 receptor activation to cardiovascular, renal, hepatic, neural, and joint anti-inflammatory effects while outlining uncertainties and future research needs.

4 Nov 2025

New review illuminates the intricate connections between gut microbiota and sleep regulation

A comprehensive review published today in Brain Medicine illuminates the intricate connections between gut microbiota and sleep regulation, establishing the microbiota-gut-brain axis as a critical pathway in understanding and potentially treating sleep disorders.

4 Nov 2025

Heatwaves can significantly worsen obstructive sleep apnea

During heatwaves, there is an increase in the number of people suffering with obstructive sleep apnoea (OSA), according to a major study published today (Wednesday) in the European Respiratory Journal.

29 Oct 2025

New clinical practice guideline provides updated recommendations for treatment of central sleep apnea

A new clinical practice guideline developed by a task force of the American Academy of Sleep Medicine provides updated recommendations for the treatment of central sleep apnea.

27 Oct 2025

New mothers more likely to experience severe pain and sleep problems after C-section

New mothers are more likely to experience severe pain that disrupts sleep and activities of daily living, as well as develop sleep disorders, if they give birth by cesarean delivery (C-section), suggests research presented at the ANESTHESIOLOGY 2025 annual meeting.

12 Oct 2025

Huawei smartwatch nearly matches gold-standard sleep test

A study reveals the HUAWEI WATCH GT2 smartwatch accurately tracks sleep stages, yet it falls short in diagnosing sleep disorders compared to PSG.

7 Oct 2025

Sleep apnea patients in high-pollution areas suffer higher disease severity, study shows

People who have obstructive sleep apnea (OSA) may suffer worse symptoms if they live in areas with higher levels of air pollution, according to a multi-national study presented at the European Respiratory Society (ERS) Congress in Amsterdam, the Netherlands.

29 Sep 2025

Daily orforglipron GLP-1 pill achieves over 11% weight loss in global obesity trial

In a phase 3 trial, once-daily oral orforglipron induced significant, dose-dependent weight loss over 72 weeks in adults with obesity but no diabetes. It also improved multiple cardiometabolic markers with a safety profile similar to other GLP-1 receptor agonists.

18 Sep 2025

CPAP treatment may reduce death risk in people with both type 2 diabetes and sleep apnea

People with both type 2 diabetes (T2D) and obstructive sleep apnea have a higher risk of death, but treatment with continuous positive airway pressure (CPAP) may reduce that risk by around 26%, according to new research being presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Vienna (15-19 Sept).

9 Sep 2025

Obstructive Sleep Apnea News and Research

Further Reading

Wake-promoting drug improves alertness in early morning shift workers

Eating melatonin-rich foods is linked to lower obesity and depression rates

New role for GLP-1 drugs: Improving survival in people with severe psychiatric disorders

Real-time smartphone monitoring improves evaluation of insomnia treatment effectiveness

Study examines fairness of oxygen desaturation thresholds in sleep apnea diagnosis

New evidence supports ablation for high-risk patients with AFib and sleep apnea

Older women with comorbid insomnia and sleep apnea show worse memory performance

Treating sleep apnea can lower Parkinson’s disease risk

New study links untreated sleep apnea to higher Parkinson’s disease risk

Exosomes identified as key mediators in obstructive sleep apnea and its comorbidities

How gut microbes shape sleep: New review reveals microbiome clues to insomnia and apnea

GLP-1 drugs calm inflammation beyond diabetes and weight loss

New review illuminates the intricate connections between gut microbiota and sleep regulation

Heatwaves can significantly worsen obstructive sleep apnea

New clinical practice guideline provides updated recommendations for treatment of central sleep apnea

New mothers more likely to experience severe pain and sleep problems after C-section

Huawei smartwatch nearly matches gold-standard sleep test

Sleep apnea patients in high-pollution areas suffer higher disease severity, study shows

Daily orforglipron GLP-1 pill achieves over 11% weight loss in global obesity trial

CPAP treatment may reduce death risk in people with both type 2 diabetes and sleep apnea

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News